🔎 Trials Near Me

Akèy › Melanom › Distrik Columbia › Washington

Etid klinik pou Melanom nan Washington, DC

17 etid pou Melanom ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Cancer Institute (NCI), Bethesda · 7 mi lwen
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
4 Weeks – 99 Years · Tout sèks · Mizajou Oct 2, 2026 · NCT00040352

Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma

Ap rekriteFaz 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou Oct 2, 2026 · NCT05155033

Evaluation for NCI Surgery Branch Clinical Research Protocols

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT00001823

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi lwen
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Ap rekriteFaz 3
  • National Cancer Institute, Bethesda · 7 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT05727904

A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Ap rekriteFaz 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou Sep 22, 2026 · NCT06066138

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Ap rekriteFaz 1/2
  • Sibley Memorial Hospital, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT05896839

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • MedStar Georgetown University Hospital, Washington D.C.
  • Children's National Medical Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi lwen
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab

Ap rekriteFaz 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 72 · Tout sèks · Mizajou Aug 20, 2026 · NCT02621021

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

Ap rekriteFaz 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 72 · Tout sèks · Mizajou Aug 13, 2026 · NCT02830724

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • National Institutes of Health, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT05592626

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Ap rekriteFaz 2
  • USA11-0, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT06953089

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Cancer Support Community Research & Training Institute, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT02333604

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Ap rekriteFaz 2/3
  • Georgetown University Medical Center, Washington D.C.
Tout laj · Tout sèks · Mizajou Apr 2, 2026 · NCT06581406

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Silver Spring · 7 mi lwen
  • Massive Bio SYNERGY-AI site, Bethesda · 7 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Ap rekrite
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Nov 27, 2024 · NCT03860883

Etid Melanom nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.